Clinical Trials on Catastrophic Antiphospholipid Syndrome
Total 33965 results
-
Meir Medical CenterUnknownDry Eye Syndromes
-
Olympic Ophthalmics, Inc.RecruitingDry Eye SyndromesUnited States
-
Daewoong Bio Inc.CompletedDry Eye SyndromesKorea, Republic of
-
Kukje PharmaCompletedDry Eye SyndromesKorea, Republic of
-
University of WashingtonNational Eye Institute (NEI); National Institutes of Health (NIH)Completed
-
Medical University of ViennaCroma-Pharma GmbHCompleted
-
Innovative MedicalCompleted
-
Instituto de Investigación Biomédica de SalamancaCarlos III Health InstituteRecruiting
-
Kind Pharmaceuticals LLCNot yet recruitingMyelodysplastic Syndromes
-
National Cancer Institute (NCI)RecruitingMyelodysplastic SyndromesUnited States
-
Syros PharmaceuticalsRecruitingMyelodysplastic SyndromesUnited States, Spain, Belgium, Israel, France, United Kingdom, Austria, Czechia, Italy, Poland, Canada, Hungary, Germany
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingMyelodysplastic SyndromesItaly
-
Syntrix Biosystems, Inc.Johns Hopkins University; Mayo Clinic; National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingMyelodysplastic SyndromesUnited States
-
Centre Hospitalier Universitaire, AmiensRecruitingMyelodysplastic SyndromesFrance
-
The University of Hong KongRecruiting
-
Washington University School of MedicineSunesis PharmaceuticalsCompletedMyelodysplastic SyndromesUnited States
-
Sclnow Biotechnology Co., Ltd.SuspendedMyelodysplastic SyndromesChina
-
NYU Langone HealthPerlmutter Cancer CenterCompletedMyelodysplastic SyndromesUnited States
-
Gilead SciencesTerminatedMyelodysplastic SyndromesUnited States, Spain, Belgium, Australia, France, Hong Kong, Hungary, Finland, New Zealand, Germany, Netherlands, United Kingdom, Italy, Switzerland, Portugal, Canada, Austria, Czechia, Norway, Poland, Turkey
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada
-
Sohag UniversityCompletedMyelodysplastic SyndromesEgypt
-
National Cancer Institute (NCI)Active, not recruiting
-
CrystalGenomics, Inc.Active, not recruitingMyelodysplastic SyndromeKorea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.SuspendedMyelodysplastic SyndromesChina
-
Karyopharm Therapeutics IncWithdrawn
-
SymBio PharmaceuticalsCompleted
-
TakedaNo longer available
-
Istituto Clinico HumanitasActive, not recruiting
-
CelgeneCompletedMyelodysplastic SyndromeSpain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
-
University Hospital, BordeauxActive, not recruitingMyelodysplastic SyndromesFrance
-
Gustavo RiveroBaylor College of MedicineTerminatedMyelodysplastic SyndromesUnited States
-
Assiut UniversityCompletedMyelodysplastic Syndromes
-
Groupe Francophone des MyelodysplasiesCompleted
-
MedPacto, Inc.CompletedMyelodysplastic SyndromesUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedMyelodysplastic SyndromeItaly
-
Genzyme, a Sanofi CompanyCompletedMyelodysplastic SyndromesUnited States, Canada
-
Array Biopharma, now a wholly owned subsidiary...CompletedMyelodysplastic SyndromesUnited States
-
Kura Oncology, Inc.Terminated
-
CelgeneCompletedMyelodysplastic SyndromesTaiwan
-
University of CincinnatiGenentech, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Istituto Clinico HumanitasUnknownMyelodysplastic SyndromesItaly, Germany, France, Spain
-
Weill Medical College of Cornell UniversityCelgeneTerminatedMyelodysplastic SyndromeUnited States
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, France, Spain, Australia, Czechia, United Kingdom, Italy, Germany, Greece, Poland, Russian Federation, Bulgaria, Sweden, Netherlands, Hungary
-
Eli Lilly and CompanyCompletedMyelodysplastic SyndromesGermany, Spain, Italy
-
Groupe Francophone des MyelodysplasiesMerck Sharp & Dohme LLCTerminated
-
St. Petersburg State Pavlov Medical UniversityTerminated
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelodysplastic SyndromeUnited States